Log in

OTCMKTS:MPHMF - Callitas Health Stock Price, Forecast & News

$0.11
0.00 (0.00 %)
(As of 02/28/2020 08:00 AM ET)
Today's Range
$0.11
Now: $0.11
$0.11
50-Day Range
$0.00
MA: $0.04
$0.11
52-Week Range
$0.00
Now: $0.11
$0.15
Volume10,000 shs
Average Volume2,100 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta0.26
Callitas Health, Inc is a clinical stage company. It engages in the development of technologies for obesity, weight management, and female health and wellness. The company focuses on developing technologies for weight management, female sexual health and wellness, cannabis delivery technologies and other proprietary drugs. It launched product ToConceive in North America. Read More…

Industry, Sector and Symbol

Industry Crude petroleum & natural gas
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:MPHMF
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive MPHMF News and Ratings via Email

Sign-up to receive the latest news and ratings for MPHMF and its competitors with MarketBeat's FREE daily newsletter.


Callitas Health (OTCMKTS:MPHMF) Frequently Asked Questions

What is Callitas Health's stock symbol?

Callitas Health trades on the OTCMKTS under the ticker symbol "MPHMF."

Has Callitas Health been receiving favorable news coverage?

News articles about MPHMF stock have trended negative recently, according to InfoTrie. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Callitas Health earned a coverage optimism score of -2.8 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Callitas Health.

Who are some of Callitas Health's key competitors?

What other stocks do shareholders of Callitas Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Callitas Health investors own include Sangamo Therapeutics (SGMO), Kirkland Lake Gold (KLG), Stornoway Diamond (SWY), Polymet Mining (POM), Aurora Cannabis (ACB), Insperity (NSP), Solaredge Technologies (SEDG), Incyte (INCY), Gilead Sciences (GILD) and BioCryst Pharmaceuticals (BCRX).

Who are Callitas Health's key executives?

Callitas Health's management team includes the folowing people:
  • James M. Thompson, President, Chief Executive & Operating Officer
  • Gary Stephens, Chief Financial Officer
  • Joshua Maurice, Vice President-Sales & Business Development

How do I buy shares of Callitas Health?

Shares of MPHMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Callitas Health's stock price today?

One share of MPHMF stock can currently be purchased for approximately $0.11.


MarketBeat Community Rating for Callitas Health (OTCMKTS MPHMF)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  80 (Thanks for Voting!)
Underperform Votes:  99 (Thanks for Voting!)
Total Votes:  179
MarketBeat's community ratings are surveys of what our community members think about Callitas Health and other stocks. Vote "Outperform" if you believe MPHMF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MPHMF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel